Le lymphocyte TH17 dernier-né de la famille des lymphocytes T CD4+

  • Essakalli M
  • Brick C
  • Bennani N
 et al. 
  • 4

    Readers

    Mendeley users who have this article in their library.
  • 3

    Citations

    Citations of this article.

Abstract

In recent years the T CD4+ lymphocyte family has grown. In the initial two components TH1 and TH2 lymphocytes were added the TH17 lymphocyte and T cell regulator (Treg). Under the influence of transforming growth factor β, interleukin 6 (IL6), IL21 and IL23, the naive lymphocyte T CD4+ differentiates in TH17. Currently, the TH17 is recognized as the leading actor of local inflammation through the pro-inflammatory cytokines (interleukins 17, 21, 22) that secretes and the expansion and recruitment of neutrophils that leads. Therefore, it is involved in chronic inflammatory processes, autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus), allergy and rejection of allogeneic transplants. TH17 lymphocyte opens up new therapeutic prospects for these pathologies. © 2009 Elsevier Masson SAS.

Author-supplied keywords

  • IL17
  • Inflammation
  • Neutrophils
  • T CD4+
  • TH17

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • M. Essakalli

  • C. Brick

  • N. Bennani

  • N. Benseffaj

  • S. Ouadghiri

  • O. Atouf

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free